Form 4: Arcutis Biotherapeutics Director Howard G. Welgus Sells 10,000 Shares

Director Howard G. Welgus sold 10,000 shares of Arcutis Biotherapeutics (ARQT) common stock on November 1, 2024, at a weighted average price of $8.6541 per share, according to a Form 4 filing with the SEC.

Summary

• On November 1, 2024, Howard G. Welgus, a director of Arcutis Biotherapeutics, Inc. (ARQT), sold 10,000 shares of common stock.
• The sale was executed at a weighted average price of $8.6541 per share.
• The transactions were made pursuant to a pre-arranged 10b5-1 trading plan.
• Following the transaction, Welgus directly owns 171,944 shares of Arcutis Biotherapeutics common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by a company director. The sentiment is neutral as it simply reports a transaction.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning. It's important to consider the overall trend of insider transactions and the company's performance when evaluating the significance of this sale.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, but it is a relatively small transaction and was conducted under a pre-arranged trading plan.

Key Dates